Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4MZY
|
||||
| Drug Name |
N-((S)-3-(4,4-dimethylcyclohexyl)-1-((4S,7R)-7-methyl-3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-ylamino)-1-oxopropan-2-yl)furan-2-carboxamide
|
||||
| Synonyms |
CHEMBL1807699
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C28H38N4O6S
|
||||
| Canonical SMILES |
C[C@@H]1CC[C@H](NC(=O)[C@H](CC2CCC(C)(C)CC2)NC(=O)c3occc3)C(=O)CN1S(=O)(=O)c4ccccn4
|
||||
| InChI |
InChI=1S/C28H38N4O6S/c1-19-9-10-21(23(33)18-32(19)39(36,37)25-8-4-5-15-29-25)30-26(34)22(31-27(35)24-7-6-16-38-24)17-20-11-13-28(2,3)14-12-20/h4-8,15-16,19-22H,9-14,17-18H2,1-3H3,(H,30,34)(H,31,35)/t19-,21+,22+/m1/s1
|
||||
| InChIKey |
BVIAUHFJTQDKSF-HJNYFJLDSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.